Hypoplastic Left Heart Syndrome clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

    open to eligible people ages up to 15 months

    The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process, outcome, and developmental data on infants with HLHS between diagnosis and 12 months of age, by improving the use of standards into everyday practice across pediatric cardiology centers, and by engaging parents as partners in the process.

    Los Angeles, California and other locations

Our lead scientists for Hypoplastic Left Heart Syndrome research studies include .

Last updated: